TARA (TARA) Stock Price & Analysis
TARA (TARA) fell 0.76% to USD 3.94 as of September 8, 2026 at 05:47 UTC, according to Nexqual real-time market data.
TARA last closed at USD 3.94; the session ranged USD 3.89–3.96 on volume of 203,006 shares. Market capitalization is —, with a 52-week range of USD 3.02–7.82 (NGM). Source: Nexqual, September 8, 2026 at 05:47 UTC.
Key Statistics (as of September 8, 2026 at 05:47 UTC)
| Price | USD 3.94 |
|---|---|
| Change | ▼ 0.76% (down) |
| Previous Close | USD 3.94 |
| Open | USD 3.94 |
| Day Range | USD 3.89 – 3.96 |
| 52-Week Range | USD 3.02 – 7.82 |
| Volume | 203,006 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (TARA)
Nexqual's technical model rates TARA "SELL" based on 1 bullish and 4 bearish signals across 128 daily candles, as of September 8, 2026 at 05:47 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 48.37 (neutral) |
| vs SMA50 | Below (USD 4.01) |
| MACD | -0.03 (negative) |
From TARA's Latest SEC 10-K Filing (filed 2026-03-10)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LRMR | Larimar Therapeutics, Inc. | USD 3.83 | ▼ 1.03% |
| TRVI | Trevi Therapeutics, Inc. | USD 17.26 | ▲ 1.23% |
| PMVP | PMV Pharmaceuticals, Inc. | USD 1.29 | ▲ 2.38% |
| CYCN | Cyclerion Therapeutics, Inc. | USD 4.25 | ▲ 0% |
| MNPR | Monopar Therapeutics Inc. | USD 117.56 | ▲ 1.1% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:47 UTC. This page is informational and not investment advice.